Luis Calvo

Showing 1-5 of 5 articles

Primary percutaneous coronary intervention for ST-segment elevation acute myocardial infarction in nonagenarian patients: results from a Spanish multicentre registry

Salinas P, Galeote G, Martin-Reyes R, Pérez-Vizcayno M, Hernández-Antolín R, Mainar V, Moreu J, de la Torre Hernandez J, Zueco J, Tello A, Jiménez-Valero S, Sanchez Recalde A, Calvo L, Plaza I, Alfonso F, Mariscal F, de Sa E, Macaya C, López-Sendón J-L, Moreno R

April 20, 2011

Periprocedural (30-day) risk of myocardial infarction after drug-eluting coronary stent implantation: a meta-analysis comparing cobalt-chromium and stainless steel drug-eluting coronary stents

Moreno R, Jiménez-Valero S, Sanchez Recalde A, Galeote G, Calvo L, Martin-Reyes R, Sabaté M, Plaza I, Macaya C, López-Sendón J-L

March 21, 2011

A randomised comparison between everolimus-eluting stent and sirolimus-eluting stent in chronic coronary total occlusions. Rationale and design of the CIBELES (non-acute Coronary occlusion treated By EveroLimus-Eluting Stent) trial

Moreno R, Garcia E, Teles R, Almeida M, Carvalho H, Sabaté M, Martin-Reyes R, Rumoroso J-R, Galeote G, Goicolea F, Moreu J, Mainar V, Mauri J, Ferreira R, Valdes M, Pérez de Prado A, Martin-Yuste V, Jiménez-Valero S, Sanchez Recalde A, Calvo L, de Sa E, Macaya C, López-Sendón J-L

May 25, 2010

Safety and efficacy of drug-eluting stents versus bare-metal stents in saphenous vein grafts lesions: a meta-analysis

Sanchez Recalde A, Valero S, Moreno R, Barreales L, Lozano I, Galeote G, Reyes R, Calvo L, López-Sendón J-L

May 25, 2010

Lower levels of in-stent late loss are not associated with the risk of stent thrombosis in patients receiving drug-eluting stents

Rivero F, Moreno R, Barreales L, Galeote G, Sanchez Recalde A, Calvo L, Jiménez-Valero S, Villate A, Vanegas M, López-Sendón J-L

May 13, 2008

1

Latest news

State of the Art on ViV-TAVI; Transseptal Punctures; Endovascular Closure and TF-TAVI; Percutaneous PVL Closure: Long-Term Outcomes; and more

October 20, 2021

STATE OF THE ART

Valve-in-valve TAVI: a practical overview

Giuseppe Tarantini et al.

October 20, 2021

TAVI in younger (<70 years old) patients: the AMTRAC registry

Guy Witberg et al.

October 22, 2021

Impact of LVOT calcification in transfemoral TAVI patients

L. Waldschmidt et al.

October 19, 2021

My Stroke Story

October 20, 2021

Impact of preprocedural biological markers on 10-year mortality in the SYNTAXES trial

Hironori Hara et al.

October 22, 2021

Serum caffeine causes adenosine-induced FFR overestimation

Hideaki Tanaka et al.

October 15, 2021

Valvular disease